COVID-19 Updates

Visit UC San Diego's Coronavirus portal for the latest information for the campus community.

Recent Trainee Accomplishments

UCSD Psychiatry Research Residents:

 Monica Castillo, M.D., M.S. (PGY-I)

Recent Honors:
2020 ACNP Travel Award

 Monica Federoff, M.D., Ph.D. (PGY-III)

Recent Honors:
2020 NIMH Outstanding Research Award Program

 Sara Timtim, M.D. (PGY-IV)
Publications During UCSD Research Residency: 
Timtim S, Welsh DK. Circadian Rhythms Disorders and Chronotherapy for Mood Disorders. In Sleep Medicine and Mental Health: A Guide for Psychiatrists and Other Healthcare Professionals. New York, NY: Springer (2020)

 Juan Molina, M.D. (Graduated June 2020)
Recent Honors
2017: NIH LRP Award, "Identification of Neurophysiologic Biomarkers of Treatment Response to Targeted Cognitive Therapy in Schizophrenia"
2018: APA Minority Fellowship award ($25,000)
2019: APA Research Colloquium Travel Award
2019: ACNP Travel Award
2020 SIRS Travel Award
2020 Justine I. Cohen Award for Schizophrenia Research

Publications During UCSD Research Residency:
Molina et al. Memantine effects on EEG measures of cortical excitatory/inhibitory balance in schizophrenia. Biological Psychiatry: Cognitive Neuroscience Neuroimaging 5: 562-8, 2020.
Molina et al. Gamma oscillations predict pro-cognitive response to auditory-based cognitive training in schizophrenia (submitted).
Light GA, Joshi YB, Molina JL et al. Neurophysiological biomarkers for schizophrenia therapeutics. Biomarkers in Neuropsychiatry 2: 1-7, 2020.
Hochberger WC, Thomas ML, Joshi YB, Molina J et al. Oscillatory biomarkers of early auditory information processing predict cognitive gains following targeted cognitive training in schizophrenia patients. (2020). Schizophrenia Research 215, 97-104.
Joshi Y, Thomas ML, Hochberger WC, Bismark AW, Treichler EB, Molina J et al. (2019). Verbal learning deficits associated with increased anticholinergic burden is attenuated with targeted cognitive training in treatment refractory schizophrenia patients. Schizophrenia Research 208, 384-389.
 

 Matt Klein, M.D., Ph.D. (Graduated June 2020)

Recent Honors:
2018 Travel Award, Society of Biological Psychiatry
2018 NIMH Outstanding Resident Award
2018 APA Research Colloquium Travel Award
2019 ACNP Travel Award
2020 American Foundation for Suicide Prevention Early Investigator Award ($90,000)
2020 Lewis L. Judd, M.D. Resident Research Award

Publications During UCSD Research Residency:

Klein ME et al.  Ketamine is not an opioid, but requires opioid system, for anti depressive actions: Cellular and behavioral studies in rodents. Proc Natl Acad Sci U S A. 117:2656-2662, 2020.
Malinow R, Klein ME. Reply to Hashimoto: Ketamine is not an opioid but requires opioid system for antidepressant actions. Proc Natl Acad Sci U S A. 117:11202-11203, 2020.
Klein ME et al.   Sam68 promotes translation-dependent long-term depression in distal dendritic regions of CA1 hippocampal neurons. Cell Reports 29:1789-1799, 2019.